Search
for

    Sort by

    Research 61–90 of 1000+

    1. METTL1-mediated m7G tRNA modification drives papillary thyroid cancer progression and metastasis by regulating the codon-specific translation of TNF-α Cell Death and Disease · 2025 · 3 citations
    2. The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy Journal of Cancer Therapy · 2022 · 1 citations
    3. Colorectal cancer co-opts an epidermal wound healing program during metastasis to generate disseminated tumor cells Nature Communications · 2026
    4. Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs DSpace@MIT (Massachusetts Institute of Technology) · 2018
    5. Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer Annals of oncology · 2004 · 1461 citations
    6. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma Cancer · 2000 · 388 citations
    7. Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany Therapeutic Advances in Medical Oncology · 2023 · 34 citations
    8. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma 2016 · 32 citations
    9. Lichenoid dermatitis from interferon alpha-2a in a patient with metastatic renal cell carcinoma and seronegative HCV Journal of The American Academy of Dermatology · 2016 · 4 citations
    10. The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature review Journal of Cancer Survivorship · 2026
    11. Understanding the symptoms and impacts of living with metastatic pancreatic adenocarcinoma: a prospective, noninterventional qualitative study The Oncologist · 2025
    12. Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study Drug Design Development and Therapy · 2025
    13. Axitinib-induced repigmentation of grey hair in a patient with metastatic renal cell carcinoma BMJ Case Reports · 2025
    14. 8273 ACTH-Dependent Cushing's Syndrome due to Metastatic Cervical Cancer: A Case Report Journal of the Endocrine Society · 2024
    15. 8273 ACTH-Dependent Cushing's Syndrome Due To Metastatic Cervical Cancer: A Case Report Journal of the Endocrine Society · 2024
    16. The Effect of Mushroom Beta‐Glucans from Solid Culture of <i>Ganoderma lucidum</i> on Inhibition of the Primary Tumor Metastasis Evidence-based Complementary and Alternative Medicine · 2014 · 23 citations
    17. MiR-325-3p functions as a suppressor miRNA and inhibits the proliferation and metastasis of glioma through targeting FOXM1 Journal of Integrative Neuroscience · 2021 · 16 citations
    18. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy The Journal of Urology · 2024 · 4 citations
    19. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024
    20. Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study Frontiers in Cell and Developmental Biology · 2024
    21. Inferring Spatially Resolved Transcriptomics Data from Whole Slide Images for the Assessment of Colorectal Tumor Metastasis: A Feasibility Study bioRxiv (Cold Spring Harbor Laboratory) · 2022
    22. Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Journal of Clinical Oncology · 2018
    23. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    24. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    25. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma British Journal of Dermatology · 2012 · 173 citations
    26. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. PubMed · 2003 · 79 citations
    27. Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer Cancer Chemotherapy and Pharmacology · 2012 · 9 citations
    28. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
    29. The efficacy of scalp-cooling system for the prevention of chemotherapy-induced hair loss in metastatic breast cancer patients treated with eribulin Annals of oncology · 2018
    30. Ectopic Expression of a Truncated Isoform of Hair Keratin 81 in Breast Cancer Alters Biophysical Characteristics to Promote Metastatic Propensity Advanced Science · 2023